My patients are successful, driven people, and when we talk honestly about what they fear, it is rarely cancer or a heart attack. It is this. Losing themselves. Watching their own mind go while their body keeps walking around. Dementia is the diagnosis that frightens people more than death, because it takes the person and leaves the body behind.

Here is what most people do not know. By the time memory visibly slips, the disease has already been at work for twenty years or more. The damage accumulates silently, for decades, long before the first missed name or lost word. That is why it is the silent thief. And it is also why waiting for symptoms to appear means waiting until the game is nearly over.

I do not wait.

The gene everyone asks about

The first question people bring me is about their genes, specifically a gene called APOE. You inherit one copy from each parent, and the version that matters most for Alzheimer's is called APOE4. Carry one copy, the 3/4 genotype, and your risk of Alzheimer's runs roughly two to three times higher than average. Carry two copies, the 4/4 genotype, and the risk climbs sharply, on the order of eight to ten times, with something close to a 60 percent chance of developing the disease by age 85. A landmark 2024 study went further, arguing that carrying two copies is not merely a risk factor but essentially a distinct, genetically driven form of the disease, since nearly all 4/4 carriers show Alzheimer's pathology in the brain by their mid sixties.

This sounds serious, which it is. However, it is not completely penetrant - plenty of people who carry two copies never develop dementia at all.

A gene is a probability, not a prophecy. Your genotype loads the gun. Everything you do next decides whether the trigger ever gets pulled.

Why I treat carriers aggressively

When I know a patient carries one or two copies of APOE4, I do not shrug and tell them to hope for the best. I treat their daily life as the most powerful medicine they have, because it is. The 2024 Lancet Commission on dementia estimated that close to half of all cases worldwide could be prevented or delayed by addressing modifiable risk factors. Close to half. There is no drug that comes anywhere near that number. The prevention lives in the lifestyle, and for a carrier the stakes of getting it right are simply higher. Here is where I focus.

Insulin sensitivity comes first. The Alzheimer's brain is, in large part, a brain in a metabolic crisis. The link between insulin resistance and dementia is so strong that some researchers call Alzheimer's type 3 diabetes. The APOE4 brain handles glucose and fat less efficiently to begin with, so the first thing I do for a carrier is protect their metabolism: keep insulin low, keep them metabolically flexible, and treat rising blood sugar as the brain threat it is, years before it would ever register as diabetes on a standard panel. The highest leverage tools we have are movement, resistance training, and diet. There are also many medical options for improving insulin sensitivity.

Then inflammation, both through the body and inside the brain itself. Chronic inflammation is one of the engines of neurodegeneration, and APOE4 changes how the brain's own immune cells clear cellular debris, which means carriers are working with a less forgiving system. Lowering the inflammatory load through diet, sleep, training, and hunting down the hidden drivers of inflammation matters more for a carrier, not less.

Then cognitive engagement. The brain is not a passive organ that simply wears out. It builds reserve when it is challenged. Learning genuinely hard things, staying mentally engaged, refusing to coast, all of it builds a buffer the disease has to chew through before symptoms ever surface. I tell carriers to treat the mind like a muscle, because in the ways that matter here, it behaves like one.

And then social connection, which is the one people underestimate most. Isolation is not a soft or sentimental risk. It is a measured, independent driver of cognitive decline, and real connection is genuinely protective. The relationships you keep, the conversations you have, the people you stay tangled up with, are part of your dementia prevention plan whether you have ever thought of them that way or not.

The long runway

The silence of this disease is the hard part and the hopeful part at once. Hard, because it works on you for two decades before it announces itself. Hopeful, because that same silence is a runway twenty years long, a window to act, if you are willing to look early and do the work.

I would rather a patient learn at 45 that they carry risk and then spend the next forty years building a brain that resists it, than find out at 75 when the thief has already taken what it came for. Knowing is only worth anything if you act on it. My job is to make sure you act on it.

If dementia is the thing you quietly fear, and especially if it runs in your family, that fear is worth turning into a plan. That is a conversation I am glad to have.

‍